Oleksandr Usyks Controversial TKO Victory Over Rico Verhoeven Potential Financial and Industry Fallout Singapore Regulator Seeks Faster Onboarding for Private Banking Clients Brigade Enterprises Expands Hyderabad Presence with Rs 850 Crore Residential Project in Kompally Global Hiring Firm CEO Declares End of Traditional Office Jobs as Trades Surge US Secretary of State Rubio Meets Indias Modi to Strengthen Energy Ties Amid Iran Supply Disruptions Zscaler Doubles Down on AI Security with Symmetry Systems Acquisition Valuation Concerns Persist DGXX Q3 2025 Earnings Net Loss Reported Amidst Market Volatility KB Home Q1 2026 Earnings Modest EPS Beat Amid Stabilizing Housing Market DOO Q1 2026 Earnings EPS Beat Sparks Positive Market Reaction Hilltop Holdings Inc Q1 2026 Earnings EPS Beat Surprises Analysts by 30 Healthpeak Properties DOC Q1 2026 Earnings Massive EPS Surprise of 515 Driven by Strong Operations AGNCP Q1 2026 Earnings Preferred Shares Benefit as EPS Exceeds Estimates by 145 Four Corners Property Trust FCPT Falls 14 as REIT Sector Pressures Intensify W P Carey Inc WPC Mild Gain as REIT Tests Key Support Levels Permian Resources Holds Steady After Minor Decline Key Levels in Focus Rain Enhancement Technologies Warrants RAINW Trade Flat Near Key Resistance at 020 Heritage Commerce Corp HTBK Holds Steady at 1345 as Trading Remains RangeBound TakeTwo Reaffirms GTA VI November Launch Despite Weaker Annual Bookings Forecast ADXN Q1 2024 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances Cohen Steers Infrastructure Fund UTF Holds Steady Near Resistance as Sector Dynamics Shift LAUR Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher PASG Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction OXLCO Q4 2025 Earnings EPS Misses Estimates Stock Remains Flat SIMO Q1 2026 Earnings Strong EPS Beat Drives Share Price Higher SJ Q1 2025 Earnings Loss Per Share Reported Amidst Positive Stock Reaction FFBC Q1 2026 Earnings Earnings Beat Bolsters Investor Confidence DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Pipeline Advances